1.
Open Forum Infect Dis
; 9(1): ofab602, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35036464
RESUMO
COVID-19 monoclonal antibodies revolutionized the treatment for eligible patients who have tested positive for SARS CoV-2 infection in an ambulatory setting. In this short report, we describe our experience assisting in the distribution of monoclonal antibodies in Arkansas during the summer surge of the delta variant.